Prediction of human herpesvirus 6 infection after allogeneic bone marrow transplantation.
Yoshikawa
T
T
Suzuki
K
K
Ihira
M
M
Furukawa
H
H
Suga
S
S
Asano
Y
Y
Kojima
S
S
Kato
K
K
Matsuyama
T
T
D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004279:DNA, Viral / Q000097:blood; D005077:Exanthema Subitum / Q000209:etiology / Q000517:prevention & control* / Q000635:transmission; D005260:Female; D006566:Herpesviridae Infections / Q000175:diagnosis*; D015654:Herpesvirus 6, Human / Q000254:growth & development / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology; D006801:Humans; D007223:Infant; D007963:Leukocytes, Mononuclear / Q000821:virology*; D008297:Male; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D014019:Tissue Donors; D065227:Transfusion Reaction; D014184:Transplantation, Homologous / Q000009:adverse effects*; D014775:Virus Activation; D017735:Virus Latency
D000914:Antibodies, Viral; D004279:DNA, Viral